Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1COHANCE LIFESCIENCES LIMITED
02 1Chunghwa Chemical Synthesis & Biotech. Ltd
03 1Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. Spa
04 1Arevipharma GmbH
05 1Hetero Drugs Limited
06 1Raks Pharma Pvt. Limited
07 1Syn-Tech Chem. & Pharm. Co., Ltd.
08 1Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
01 1METAXALONE
02 7Metaxalone
01 1China
02 1Germany
03 3India
04 1Italy
05 2Taiwan
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 17511-104
Start Marketing Date : 2007-11-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6231
Start Marketing Date : 2018-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50056-1999
Start Marketing Date : 2000-10-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 10920-581
Start Marketing Date : 2010-11-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0089
Start Marketing Date : 2002-08-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 47621-020
Start Marketing Date : 2013-06-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54871-1087
Start Marketing Date : 2004-02-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12666-0012
Start Marketing Date : 2010-03-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Skelaxin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Skelaxin, including repackagers and relabelers. The FDA regulates Skelaxin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Skelaxin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Skelaxin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Skelaxin supplier is an individual or a company that provides Skelaxin active pharmaceutical ingredient (API) or Skelaxin finished formulations upon request. The Skelaxin suppliers may include Skelaxin API manufacturers, exporters, distributors and traders.
click here to find a list of Skelaxin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Skelaxin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Skelaxin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Skelaxin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Skelaxin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Skelaxin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Skelaxin suppliers with NDC on PharmaCompass.
We have 8 companies offering Skelaxin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
